Convelo Therapeutics, Inc. — Form D
Convelo Therapeutics, Inc. of CLEVELAND, OH, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-08. The offering totals $12.0M, of which $10.8M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2022-12-08
- Form: D
- Accession: 0001724444-22-000004
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $10.8M
- Remaining: $1.2M
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2022-12-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-466899
Issuer
- Name: Convelo Therapeutics, Inc.
- CIK: 0001724444
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 11000 CEDAR AVENUE, CLEVELAND, OH, 44106
- Phone: 2166583969
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Drew Adams | Director | Cleveland, OH |
| Ronald Richard | Director | Cleveland, OH |
| Derrick Rossi | Director | Cleveland, OH |
| Bill Sanford | Director | Manhattan, KS |
| Paul Tesar | Director | Cleveland, OH |
| Derrick Rossi | Executive Officer | Cleveland, OH |
| Steven Landau | Executive Officer | Cleveland, OH |
Other filings by this issuer (1)
More